Suppression of endogenous hydrocortisone with dexamethasone. 1980

T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling

A newly developed high-pressure liquid chromatographic method was used to study the optimum dosage regimen needed to suppress endogenous hydrocortisone. Nine volunteers were randomly placed in three groups. Each group received 1 mg of dexamethasone at 11 pm (Treatment A), 2 mg of dexamethasone at 11 pm (Treatment B), or 1 mg at 11 pm and an additional 1 mg at 6 am the following day (Treatment C). Analysis of multiple blood samples obtained the day before and the day after drug administration showed suppression in all three groups. Although the duration and extent of this suppression varied, adequate suppression to permit bioavailability studies was observed for Treatments B and C.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
June 2015, Journal of veterinary pharmacology and therapeutics,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
April 1982, Journal of pharmacokinetics and biopharmaceutics,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
August 1985, Psychiatry research,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
July 1982, Orvosi hetilap,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
January 1984, European archives of psychiatry and neurological sciences,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
February 2005, Journal of veterinary pharmacology and therapeutics,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
June 1987, Psychiatry research,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
September 1985, Journal of affective disorders,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
April 1983, Acta psychiatrica Scandinavica,
T J Goehl, and G M Sundaresan, and J P Hunt, and V K Prasad, and R D Toothaker, and P G Welling
January 1988, Psychiatria polska,
Copied contents to your clipboard!